We thrive on creating ambitious, mutually beneficial partnerships with the NHS.
Both organisations also seek to provide cost-effective new medicines to extend access for more patients and to improve health outcomes. These innovations may be reviewed and initiated at both the national level (for example in alliance with the AHSNs, Cancer Alliances and specialist networks) and regional level through the Integrated Care Boards.
The relationship between NHS and Amgen is an evolving one, particularly given the events of the COVID pandemic which has seen innovation adopted in key service areas. Amgen is committed to a model centred on collaboration to meet common goals of improved patient outcomes and more efficient use of NHS resources.
Working with the NHS, Amgen is developing improved service pathways in areas such as early diagnoses and screening, developing key laboratory biomarker diagnostic processes and optimising the patient journey through the treatment pathway.
In partnership, both Amgen and the NHS are able to identify and highlight the process flow of a service pathway, identify blocks and potential resource gaps, create a visual concept of the pathway to optimise the service.
Depending on the service pathway under consideration, the outcomes may be to
Submit your collaboration opportunity, idea or ask a question. Let Amgen become your integrated partner.
